Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 8 recruiting now full pipeline

Urinary Tract Infections: full-pipeline trial registry

8 of 35 indexed Urinary Tract Infections trials are currently recruiting.

Corpus placement: #435 of 28,707 conditions by registered trial count.

35 US clinical trials · 8 currently recruiting · #435 of 28,707 conditions by registered trial count

Urinary Tract Infections: 35 US clinical trials tracked, 8 recruiting.

Urinary Tract Infections is the subject of 35 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is National Center for Complementary and Integrative Health (NCCIH), running 3 of these trials.

Enrollment posture brief

Registry condition urinary-tract-infections

OPEN 8 | RECR 23% | LATE 5 | EARLY 7 | RANK #435 | SPON 3

Nearest open-share peer: Atherosclerosis (23% recruiting · 70 trials)

Cannabis Use Disorder71.4%Cirrhosis, Liver60%Urinary Tract Infections (th…23%Carcinoma, Renal Cell17.1%Advanced Lymphoma8.6%
Open-enrollment share among volume-matched conditions near Urinary Tract Infections

Urinary Tract Infections lists 8 open slots (23% of 35 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Urinary Tract Infections on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Urinary Tract Infections is recruiting below its size-band peers.

    8 of 35 indexed trials (22.9%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Urinary Tract Infections trials is spread across many organizations.

    National Center for Complementary and Integrative Health (NCCIH) accounts for 3 of 35 trials (8.6%). 32 distinct sponsors appear on at least one study for this condition label.

  3. Typical Urinary Tract Infections enrolment sits around 176 participants.

    Median target enrolment is 176 among the 35 trials that report a genuine target (sentinel values excluded). 11 of those (31.4%) plan for fewer than 100 participants.

  4. Urinary Tract Infections research is mostly interventional.

    30 interventional and 5 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13Phase 24Phase 33Phase 42

Open and recent trials

35 total, page 1 of 1

RECRUITING NA 2,674 participants

Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial

University of Utah

NCT05471908

RECRUITING Phase 1 448 participants

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

GlaxoSmithKline

NCT06702449

RECRUITING NA 438 participants

Double Voiding and Post-transplant UTI

Weill Medical College of Cornell University

NCT05711446

RECRUITING Phase 2 318 participants

A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)

Locus Biosciences

NCT05488340

RECRUITING NA 136 participants

Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture

University Hospitals Cleveland Medical Center

NCT06808451

RECRUITING Phase 4 100 participants

NextGen - Clinical Implication of Next Generation Sequencing

Wake Forest University Health Sciences

NCT05206500

RECRUITING 75 participants

Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study

Antonios Likourezos

NCT05227937

RECRUITING NA 47 participants

Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting

University Hospitals Cleveland Medical Center

NCT06976125

ACTIVE NOT RECRUITING NA 1,131 participants

Discharge Stewardship in Children's Hospitals

Children's Hospital of Philadelphia

NCT05826873

ACTIVE NOT RECRUITING NA 600 participants

To Wipe or Not To Wipe?: That Is The Question

Joanna A. Orzel

NCT06296901

ACTIVE NOT RECRUITING NA 200 participants

Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB

Loyola University

NCT05554081

ACTIVE NOT RECRUITING NA 142 participants

Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery

Brigham and Women's Hospital

NCT03522961

ACTIVE NOT RECRUITING Phase 4 136 participants

Chlorhexidine Lavage for Recurrent Urinary Tract Infection

Oregon Health and Science University

NCT06598514

ACTIVE NOT RECRUITING 75 participants

Qualitative Assessment of the Impact of TTNS on QOL and Participation

Medstar Health Research Institute

NCT04248322

ACTIVE NOT RECRUITING NA 8 participants

Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team

VA Office of Research and Development

NCT05319561

COMPLETED NA 2,511 participants

Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study

Pathnostics

NCT03931538

COMPLETED Phase 3 2,229 participants

Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women

Iterum Therapeutics, International Limited

NCT05584657

COMPLETED 919 participants

The Significance of Funguria in Hospitalized Patients

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

NCT00787085

COMPLETED Phase 3 661 participants

Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections

Venatorx Pharmaceuticals

NCT03840148

COMPLETED Phase 3 607 participants

Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT00405704

COMPLETED 375 participants

Early or Late Foley Removal After Thoracotomy

Mayo Clinic

NCT01611519

COMPLETED NA 330 participants

Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections

Ocean Spray Cranberries

NCT01776021

COMPLETED Phase 2 319 participants

Cranberry Juice for Treatment of Urinary Tract Infections

National Center for Complementary and Integrative Health (NCCIH)

NCT00093054

COMPLETED NA 219 participants

Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections

Coloplast A/S

NCT00318591

COMPLETED NA 201 participants

Short-course Methenamine Hippurate for Prevention of Post-operative UTI

University of Pennsylvania

NCT02358993

COMPLETED Phase 2 176 participants

Cranberry Juice for the Prevention of Recurrent Urinary Tract Infections

National Center for Complementary and Integrative Health (NCCIH)

NCT00128128

COMPLETED NA 141 participants

UTI Prophylaxis With Cranberry Extract After Female Incontinence Surgery

University of Oklahoma

NCT03898310

COMPLETED NA 100 participants

Foley Catheter vs a Self-contained Valved Urinary Catheter

charbel salamon

NCT03178734

COMPLETED 96 participants

Urine Gene Analysis for Pathogen Detection

David Sheyn

NCT05591911

COMPLETED NA 65 participants

Prevention of Urinary Tract Infection (UTI) in Persons With Spinal Cord Injury (SCI)

Baylor College of Medicine

NCT00309114

COMPLETED Phase 2 40 participants

UTI Prophylaxis Using Bacterial Interference Following SCI

US Department of Veterans Affairs

NCT00037921

COMPLETED NA 25 participants

Probiotics and Multi-Drug Resistant Urinary Tract Infection

Ochsner Health System

NCT03644966

COMPLETED Phase 1 20 participants

A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection

Hoffmann-La Roche

NCT03174795

COMPLETED NA 18 participants

Interactions Between Cranberry Juice and Antibiotics Used to Treat Urinary Tract Infections

National Center for Complementary and Integrative Health (NCCIH)

NCT00084201

COMPLETED Phase 1 3 participants

Treatment and/or Prevention of Urinary Tract Infections

Biomedical Development Corporation

NCT00801021

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 4
Phase 3 3
Phase 4 2

Named interventions

Most-linked intervention names on Urinary Tract Infections records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Meropenem Drug
2 trials
Cranberry juice Drug
2 trials
Urine Culture Diagnostic test
2 trials
Placebo Drug
2 trials
Conveen Uncoated Device
1 trials
SpeediCath Device
1 trials
Foley Catheter vs Self-Contained Valved Catheter Device
1 trials
bacterial interference Procedure
1 trials

US sites by state

Facility locations filed on Urinary Tract Infections trials. A trial with sites in several states counts in each.

Texas 8 trials
California 8 trials
Ohio 7 trials
Washington 5 trials
Pennsylvania 5 trials
New York 5 trials
New Jersey 4 trials
North Carolina 4 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Urinary Tract Infections page

35 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Urinary Tract Infections condition card totals 35 registered trials; most-linked intervention Meropenem; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.